|Title||Artificial Intelligence Molecular Screen Grants - Drug Discovery and In Silico High-throughput Screening Grants|
|Opportunity Type||Grants and Funding|
The goal of this program is to broaden the pool of scientists involved in the discovery of small molecules for the treatment and investigation of human diseases. To advance this goal, Atomwise seeks proposals from innovative university scientists to receive 72 potential medicines, generated specifically for their research by artificial intelligence. This Artificial Intelligence Molecular Screen (AIMS) program is designed to dramatically accelerate the race towards life-saving drugs by analyzing millions of compounds for each disease. Contributing AI technology and delivering physical molecules to labs across the world, the program is the first of its kind.
|Field of Interest||drug discovery, drug development, target discovery, medicinal chemistry, structural biology, therapeutics, small molecules, protein-protein interactions, medicines|
|Uploaded Sponsor Image|
|Sponsor Name||Atomwise, Inc.|